id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-308390-ei96iuw3	Wu, Junping	Recovery of Four COVID-19 Patients via Ozonated Autohemotherapy	2020-11-04		.txt	text/plain	550	36	53	We report a case series of ozonated autohemotherapy of four COVID-19 patients, classified as critically ill (1 patient), severe (1 patient), and moderate (2 patients). On the other hand, our critically ill patient underwent 9 ozonated autohemotherapy treatments and spent 10 days in the ICU and was discharged on hospital day 30; his hospitalization cost amounted to $15,466.50 USD. This case series suggests that ozonated autohemotherapy may be an alternative noninvasive medical treatment for COVID-19 patients. 10,11 These findings 53 indicate that ozonated autohemotherapy may be a new strategy to treat patients infected 54 with betacoronaviruses. Therefore, we present, for the first time, a case series of four 55 patients with different disease severities for whom ozonated autohemotherapy 56 treatments were designed and implemented by a multidisciplinary team. Four patients (age range, 56-77 years; 2 women) were treated with ozonated 58 autohemotherapy.	./cache/cord-308390-ei96iuw3.txt	./txt/cord-308390-ei96iuw3.txt